Condition: Mood Disorder (Depressive Episodes) · Sponsor: Resilience
Mood disorders like depression and bipolar disorder are widespread and cause serious psychological, cognitive, and social impairments, with a high burden on healthcare systems. Edra PRO is a digital medical device developed to support clinical decision-making and remotely monitor symptoms in psychiatric patients. The EC-102 randomized controlled trial will evaluate its impact compared to usual care on symptoms, quality of life, healthcare costs, comorbidities, and user adherence and satisfaction.
This description comes directly from the study's public registry record.
Emma Touré Cuq, PharmD · +33646396617 · emma.tourecuq@resilience.care
Charles Ferté · charles.ferte@resilience.care
Always discuss trial participation with your own doctor first.
| CHU Besançon | Besançon, France | Recruiting |
| CHU Grenoble Alpes | Grenoble, France | Recruiting |
| EPSM de VEndée | La Roche-sur-Yon, France | Recruiting |
| CHU de Lille | Lille, France | Recruiting |
| Cabinet Corinne MARIE | Lisieux, France | Recruiting |
| CHU de Toulouse | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07087353